Latest Headlines

Visterra collaborates with A*STAR to make monoclonal antibody for dengue

Visterra Inc., a clinical-stage biotechnology company with a unique technology platform to discover disease targets and create novel treatments for infectious diseases, and the Agency for Science, Technology and Research’s (A*STAR) Drug Discovery and Development (D3) unit, recently partnered to create VIS513 -- Visterra’s treatment that uses broadly neutralizing antibodies to fight dengue fever. Read More »

Microfluidic cell-squeezing tool shows promise for cell-based vaccines

Massachusetts Institute of Technology researchers recently demonstrated a microfluidic cell-squeezing device that introduces antigens to the body’s immune system’s B cells, a tool that may open a new approach to creating and implementing cell-based, antigen-presenting vaccines. Read More »

InDevR launches VaxArray for all bioprocessing stages

InDevR Inc., an innovative life science company specializing in enhancing biopharmaceutical and vaccine production, recently announced that it has launched its potency assay called VaxArray, a re-branded version of InDevR’s previously Influenza Titer on Chip or Flu-ToC. Read More »

Chemists discover simple, thrifty method to synthesize amines

A team of chemists from the Scripps Research Institute (TSRI) recently discovered a simple and cost-efficient tool for synthesizing “amines,” which are a specific class of organic compounds that are commonly used in drugs and similar modern products. This discovery is especially useful as a method to synthesize complex amines that are valued in the pharmaceutical industry, but are difficult to synthesize with regular methods. Read More »

Study explores why measles, unlike flu, only requires childhood vaccines

A study recently published in Cell Reports helps shed light on why people only need one vaccine for measles, but multiple vaccines for influenza. The study's conclusion: The proteins on the surface of the measles virus cannot invade the body’s cells if the measles virus has undergone any mutations. Read More »

Public health emergency declared in Indiana county after HIV spike

Dr. Jerome Adams, Indiana's state health commissioner,  declared  a state of public health emergency on Thursday in  Scott County, effective through May 24, 2016. The declaration was made in light of the HIV outbreak in Southeastern Indiana. There are now 160 cases of HIV in the area (159 confirmed cases and one case producing a preliminary positive test result). Read More »

Southeastern Indiana HIV outbreak at 158

Health professionals recently issued the latest update about this year's HIV outbreak in Southeastern Indiana, reporting 157 cases have been confirmed and one additional case has tested as preliminary positive. Read More »

Genocea’s Phase 2 genital herpes test shows positive results

Genocea Biosciences Inc., a biopharmaceutical company that specializes in creating immunotherapies and vaccines for T cells, recently announced positive results from its Phase 2 trial of GEN-003, the company’s new treatment for genital herpes. Read More »

World Health Organization approves new global malaria strategy

The World Health Organization (WHO) member states recently approved of the new global malaria strategy for 2016-30 and also approved of the proposed program budget for 2016-17. Read More »

New Ebola treatment increases survival rates in mice

Researchers have shown that an experimental treatment for Ebola increased the survival rates of tested mice as scientists continue searching for ways the global health community can be better prepared for any future outbreaks.   Read More »

LabCorp shares 2 new hepatitis C virus drug resistance assays
Published on Monday, May 18, 2015 @ 9:18pm by Vaccine News Daily Reports
Summer 2014 Norovirus outbreak connected to Oregon lake
Published on Monday, May 18, 2015 @ 9:10pm by Vaccine News Daily Reports
Report details responsibilities of health professionals treating Ebola
Published on Monday, May 18, 2015 @ 8:38pm by Vaccine News Daily Reports
Tuberculosis testing market estimated to expand by 2020
Published on Monday, May 18, 2015 @ 7:38pm by Vaccine News Daily Reports
UNAIDS encourages commitment to creating HIV vaccine
Published on Monday, May 18, 2015 @ 7:28pm by Vaccine News Daily Reports
Burundi refugees' deaths linked to diarrhea outbreak in Tanzania
Published on Monday, May 18, 2015 @ 6:26pm by Vaccine News Daily Reports
CDC reports decrease in foodborne infections in 2014
Published on Friday, May 15, 2015 @ 6:20pm by Vaccine News Daily Reports
Advance made in pursuit of vaccine for E. coli strains
Published on Friday, May 15, 2015 @ 5:33pm by Vaccine News Daily Reports
VBI Vaccines to present at Modern Vaccines Adjuvants & Delivery Systems Conference
Published on Friday, May 15, 2015 @ 5:24pm by Vaccine News Daily Reports
Tessier-Lavigne leaves Pfizer board for Denali post
Published on Friday, May 15, 2015 @ 5:18pm by Vaccine News Daily Reports
GSK responds to O’Neill Review's antibiotic resistance report
Published on Friday, May 15, 2015 @ 4:53pm by Vaccine News Daily Reports
Addiction counseling crucial to Southeastern Indiana HIV outbreak response
Published on Friday, May 15, 2015 @ 4:43pm by Vaccine News Daily Reports
VaxInnate adds to senior management team
Published on Thursday, May 14, 2015 @ 10:54pm by Vaccine News Daily Reports
Study: Males get some HPV cancer protection when female partners vaccinated
Published on Thursday, May 14, 2015 @ 10:20pm by Vaccine News Daily Reports
New test may detect resistant TB faster
Published on Thursday, May 14, 2015 @ 8:27pm by Vaccine News Daily Reports
Maine CDC urges baby boomers to get hepatitis C test
Published on Thursday, May 14, 2015 @ 8:19pm by Vaccine News Daily Reports
Study examines neurological damage in HIV patients
Published on Thursday, May 14, 2015 @ 8:10pm by Vaccine News Daily Reports
Latest update for Indiana HIV outbreak
Published on Thursday, May 14, 2015 @ 6:57pm by Vaccine News Daily Reports
Positive results released from two pivotal clinical smallpox vaccine studies
Published on Thursday, May 14, 2015 @ 4:56am by Vaccine News Daily Reports
NYVAC-HIV vaccine applied in HVTN 092 and HVTN 096 clinical trials
Published on Thursday, May 14, 2015 @ 4:48am by Vaccine News Daily Reports

← Older Stories